Sean khozin md. Following residency training in internal medicine, Dr.



Sean khozin md. Location: New York City Metropolitan Area · 500+ connections on LinkedIn. Sean Khozin is an oncologist in New York, New York. tech. Click to read PhyusionBio, by Sean Khozin, MD, MPH, a Substack publication with hundreds of subscribers. Dr. Sean Khozin, MD, MPH is a physician-scientist and oncologist, i nternationally recognized for his leadership in leveraging data science, AI, machine learning, and real-world evidence to drive innovation in biomedical research, with a particular emphasis on oncology drug development. He received his medical degree from University of Maryland School of Medicine and has been in practice for more than 20 years. ai. He is a physician-executive, board certified oncologist, and data scientist who is globally recognized as a leader in drug development, regulation, and applications of artificial intelligence and machine learning in biomedical research and therapeutic development. He joined the company from US FDA’s Oncology Center of Excellence, where he led the Center’s bioinformatics efforts. Physician-Scientist | Oncologist [Opinions my own] Sean Khozin, MD, MPH The CEO Roundtable on Cancer (CEORT) announced today the appointment of Sean Khozin, MD, MPH, as its next chief executive officer. Khozin completed fellowship training at the National Cancer Institute (NCI) and is a board-certified oncologist. View Sean Khozin’s profile on LinkedIn, a professional community of 1 billion members. Jul 22, 2025 · From Breakthrough to Breakdown: The $900 Million FDA Rejection Letter FDA's RP1 Rejection Signals Regulatory Transformation Sean Khozin, MD, MPH Jul 22, 2025 Sean Khozin, MD, MPH Sean Khozin, MD, MPH is a physician-scientist and Global Head of Data Science Innovation at Janssen R&D. Jan 12, 2021 · Sean Khozin, MD, MPH, has been named chief executive officer of CancerLinQ ® LLC, a wholly-owned nonprofit subsidiary of ASCO. . US Food and Drug Administration approval summary: Erlotinib for the first-line treatment of metastatic non-small cell lung cancer with epidermal growth factor receptor exon 19 … S Khozin, GM Following residency training in internal medicine, Dr. Sean Khozin, MD, MPH, on Delivering Precision Cancer Care in the Era of Digital Medicine MEET CANCERLINQ CEO SEAN KHOZIN, MD, MPH Sean Khozin named CEO of CancerLinQ: AI is here, and it will become even more democratized Tech Tonics Podcast: Sean Khozin, Attuned To Data Science CEO Rountable on Cancer: Maintaining Clinical Trial Integrity Amid bio. smzn0 l9bc l4x pc6 grmqa unekxos opkap vbzyucyu f9iq36 mjrfqp